In the general population,<unk><unk> <unk><unk>  occurs in about 0.5% of men in a given year. It is found in men of any age, with the peak incidence in men aged 35–45 years. However, the overall prevalence of symptoms suggestive of<unk>  is 6.3%. The role of the prostate was questioned in the cause of<unk>  when both men and women in the general population were tested using the (1) National Institutes of Health<unk><unk>  Symptom Index (NIH-CPSI) —with the female homologue of each male anatomical term used on questionnaires for female participants— (2) the International Prostate Symptom Score (IPSS), and (3) additional questions on<unk> <unk> . The prevalence of symptoms suggestive of CPPS in this selected population was 5.7% in women and 2.7% in men, placing in doubt the role of the prostate gland. New evidence from 2008 suggests that the prevalence of<unk>  is much higher in teenage males than once suspected.
Chronic prostatitis/chronic pelvic pain syndrome
Benign prostatic hyperplasia
symptom of Benign prostatic hyperplasia
Cancer
symptom of Urethral cancer
Prostatitis
symptoms of Bladder cancer
Overactive bladder